美股詳情

本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

美國抗疫概念

1,545.37

-3.8544-0.25%

漲家數：16

跌家數：3

平家數：- -

市盈率：- -

高：1,552.74

開：1,549.11

低：1,539.68

收：1,549.22

成交量：6,899.97萬

成交額：37.57億

市值：1.27萬億

流通市值：1.25萬億

資料載入中...

世界級研發中心扎堆落户，中國醫療創新加速輸出全球

阿斯利康全球研發北京戰略中心啓用加速推進新一代創新藥物研發

中国网财经

跨國藥企為何都愛來中國開研發中心？輝瑞研發副總裁陳朝華：又快又好！

每日经济新闻

阿斯利康在京啓用全球戰略研發中心

Icotrokinra長期結果確認靶向口服肽在難治性頭皮和生殖器銀屑病中具備良好療效和安全性

Nanobiotix Sa - 關於Nanoray-312及其他與Jnj-1900 (Nbtxr3)相關的強生讚助研究的未來指引將由強生髮布

Aethlon Medical, Inc.盤中異動股價大漲5.57%

Moderna股價下跌1.7%，因公司在試驗受挫後暫停鉅細胞病毒疫苗的研發

研究公司稱，如果藥物定價與基準掛鈎，美國本可節省 15 億美元成本

跨國藥企高層：進博會強大「溢出效應」成全球創新成果落地「加速器」

中国新闻网

吉利德展示Livdelzi®（Seladelpar）在原發性膽汁性膽管炎（PBC）中的長期療效階段性數據以及針對慢性乙型肝炎的研究藥物Bulevirtide

BUZZ-出生缺陷疫苗試驗未達標，莫德納股價下跌

Moderna股價在盤前交易中下跌4.3%，因公司因試驗挫折暫停出生缺陷疫苗的開發

試驗失敗後，莫德納終止了 CMV 疫苗的研發

Moderna公佈的III期研究顯示，實驗性鉅細胞病毒(CMV)疫苗未達到主要療效指標

Moderna - 不預計其2025年財務指引或2028年實現盈虧平衡的預期受到任何影響

Moderna將繼續在進行中的第二階段臨牀試驗中評估MRNA-1647在骨髓移植患者中的應用

Vir Biotechnology將在2025年11月5日發佈企業更新及2025年第三季度財務業績

波士頓科學公司因心臟設備需求強勁而上調年度利潤預期

中文去中心化合約交易所孫悟空上線 APT、NEAR、TAO、SNX、KGEN USDT 本位合約交易

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/hant/stock/BK4568/news"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK4568","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4568\",,,,,undefined,":{"symbol":"BK4568","market":"US","secType":"PLATE","nameCN":"美國抗疫概念","latestPrice":1545.3685,"timestamp":1761335999999,"preClose":1549.2229,"halted":0,"volume":68999652,"delay":0,"changeRate":-0.002488,"floatShares":0,"shares":0,"eps":0,"marketStatus":"休市中","change":-3.85437,"latestTime":"10-24 16:00:00 EDT","open":1549.1096,"high":1552.7437,"low":1539.6848,"amount":3756770681.191848,"amplitude":0.008429,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1761552000000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"pbRate":4.031525,"peRate":20.927329,"turnoverRate":0.004494,"increases":16,"decrements":3,"flats":0,"marketCap":1268217594292,"floatMarketCap":1247480072553},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4568\",,,,,undefined,":{"symbol":"BK4568","high":1552.7437,"amplitude":0.008429,"preClose":1549.2229,"low":1539.6848,"pbRate":"4.031525","latestPrice":1545.3685,"volume":68999652,"delay":0,"open":1549.1096,"prevYearClose":1274.8187,"prevWeekClose":1562.9379,"prevMonthClose":1508.8958,"prevQuarterClose":1508.8958,"fiveDayClose":1562.9379,"twentyDayClose":1468.6451,"sixtyDayClose":1401.1527,"secType":"PLATE","market":"US","turnoverRate":0.004494,"peRate":20.927329,"marketCap":1268217594292,"floatMarketCap":1247480072553,"timestamp":1761335999999,"nameCN":"美國抗疫概念"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK4568\",,,,undefined,":{"bkCode":"BK4568","up":16,"down":3,"flat":0},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK4568\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2578634763","title":"世界級研發中心扎堆落户，中國醫療創新加速輸出全球","url":"https://stock-news.laohu8.com/highlight/detail?id=2578634763","media":"第一财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2578634763?lang=zh_tw&edition=fundamental","pubTime":"2025-10-26 19:15","pubTimestamp":1761477327,"startTime":"0","endTime":"0","summary":"10月25日，两大跨国医疗巨头阿斯利康和美敦力同一天在北京宣布落成新的研发中心和创新基地，中国作为全球医疗创新策源中心的地位正在进一步加固。数十年前进入中国的一大批跨国医疗企业，正在从单纯的技术输入者，成长为中国医疗行业重要的生态共创者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202510263544498452.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202510263544498452.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK4534","LU1066051498.USD","SG9999001176.USD","LU0321505439.SGD","SG9999002224.SGD","BK4581","IE00BLSP4452.SGD","IE0002270589.USD","PFE","BK4533","LU0289739699.SGD","LU1894683264.USD","BK4007","LU1883839398.USD","BK4588","BK4592","LU1057294990.SGD","LU0122379950.USD","BK4599","IE00BBT3K403.USD","LU0306807586.USD","SG9999001176.SGD","SG9999002232.USD","LU0234572021.USD","BK4568","IE00B19Z3B42.SGD","LU0868494617.USD","SG9999003800.SGD","BK4585","LU0225284248.USD","LU0456855351.SGD","LU0985481810.HKD","LU0058720904.USD","LU0170899867.USD","LU0225771236.USD","IE000M9KFDE8.USD","SG9999013999.USD","LU0306806265.USD","LU0321505868.SGD","BK4550","LU1066053197.SGD","IE00BLSP4239.USD","SGXZ57979304.SGD","LU1023059063.AUD","LU1894683348.USD","SG9999011175.SGD","IE00B19Z3581.USD"],"gpt_icon":1},{"id":"2578050393","title":"阿斯利康全球研發北京戰略中心啓用 加速推進新一代創新藥物研發","url":"https://stock-news.laohu8.com/highlight/detail?id=2578050393","media":"中国网财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2578050393?lang=zh_tw&edition=fundamental","pubTime":"2025-10-25 21:58","pubTimestamp":1761400690,"startTime":"0","endTime":"0","summary":"中国网财经10月25日讯阿斯利康今日在京正式启用全新全球战略研发中心，这是阿斯利康全球第六个、在华第二个战略研发中心。作为公司25亿美元(约合180亿人民币)投资计划的核心项目，全球研发北京战略中心拥有先进的人工智能和数据科学中心，旨在加速药物早期研究成果向临床开发的转化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202510253544333566.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202510253544333566.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU0109394709.USD","LU1829250122.USD","BK4588","LU2417539215.USD","BK4585","BK4568","LU2456880835.USD","BK4007","LU2236285917.USD","BK1574","LU0889565916.HKD","LU2462157665.USD","LU0320765992.SGD","06978","AZN","BK1161"],"gpt_icon":0},{"id":"2578150877","title":"跨國藥企為何都愛來中國開研發中心？輝瑞研發副總裁陳朝華：又快又好！","url":"https://stock-news.laohu8.com/highlight/detail?id=2578150877","media":"每日经济新闻","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2578150877?lang=zh_tw&edition=fundamental","pubTime":"2025-10-25 20:48","pubTimestamp":1761396490,"startTime":"0","endTime":"0","summary":"2023年2月，《人民日报海外版》以“中国出实招欢迎外资研发中心”为题刊发了一篇文章，探究了十年间中国规模以上外商投资工业企业研发投入增长91.5%背后的原因。此后两年，“创新药”连续两年出现在政府工作报告中，该领域的外资投资消息纷至沓来。今年10月，辉瑞（北京）研究开发有限公司（下称“辉瑞北京研发中心”）迎来成立一周年。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202510253544326536.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202510253544326536.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["IE00BLSP4239.USD","LU1066051498.USD","LU1894683348.USD","LU0321505439.SGD","IE00B19Z3581.USD","LU0456855351.SGD","BK4533","SG9999011175.SGD","IE000M9KFDE8.USD","LU0058720904.USD","IE0002270589.USD","LU1894683264.USD","IE00BBT3K403.USD","LU0321505868.SGD","SG9999013999.USD","LU0225284248.USD","LU0868494617.USD","BK4581","LU0306807586.USD","BK4534","IE00BLSP4452.SGD","BK4592","SG9999001176.USD","SGXZ57979304.SGD","LU0985481810.HKD","BK4007","PFE","LU0170899867.USD","BK4550","LU0225771236.USD","BK4599","LU0122379950.USD","SG9999002232.USD","LU0234572021.USD","SG9999003800.SGD","LU1883839398.USD","IE00B19Z3B42.SGD","LU1023059063.AUD","SG9999002224.SGD","LU1057294990.SGD","SG9999001176.SGD","BK4585","LU0289739699.SGD","BK4588","BK4568","LU0306806265.USD","LU1066053197.SGD"],"gpt_icon":1},{"id":"2578557401","title":"阿斯利康在京啓用全球戰略研發中心","url":"https://stock-news.laohu8.com/highlight/detail?id=2578557401","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2578557401?lang=zh_tw&edition=fundamental","pubTime":"2025-10-25 17:48","pubTimestamp":1761385697,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["LU1829250122.USD","BK4585","AZN","LU0889565916.HKD","LU0320765992.SGD","BK4007","BK4568","LU2417539215.USD","LU0109394709.USD","LU2236285917.USD","BK4588","LU2462157665.USD","LU2456880835.USD"],"gpt_icon":0},{"id":"1175418704","title":"Icotrokinra長期結果確認靶向口服肽在難治性頭皮和生殖器銀屑病中具備良好療效和安全性","url":"https://stock-news.laohu8.com/highlight/detail?id=1175418704","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1175418704?lang=zh_tw&edition=fundamental","pubTime":"2025-10-24 20:02","pubTimestamp":1761307344,"startTime":"0","endTime":"0","summary":"Icotrokinra长期结果确认靶向口服肽在难治性头皮和生殖器银屑病中具有高比例的持久皮肤清除率和良好的安全性.","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0234570918.USD","LU1732799900.SGD","IE00BSNM7G36.USD","LU2471134523.USD","JNJ","IE00B3PB1722.GBP","LU1057294990.SGD","LU0345770993.USD","IE00B7SZLL34.SGD","BK4534","LU0882574055.USD","LU0795875086.SGD","LU1496350502.SGD","IE00B1BXHZ80.USD","LU1244550494.USD","LU2750360641.GBP","SG9999001440.SGD","LU1032955483.USD","IE00B42XCP33.USD","LU0114720955.EUR","BK4568","LU1059921491.USD","BK4504","LU0345770308.USD","LU0289739699.SGD","LU1066051225.USD","LU2750360997.AUD","BK4533","LU1585245621.USD","LU1674673691.USD","LU2347655156.SGD","LU0345769128.USD","LU2133065610.SGD","LU2089984988.USD","LU1066051498.USD","LU0912757837.SGD","IE00BGHQF631.EUR","LU1914381329.SGD","LU2129689514.USD","IE0002270589.USD","LU0098860793.USD","LU1430594728.SGD","LU1894683348.USD","LU2602419157.SGD","LU1066051811.HKD","LU0640476718.USD","LU1732800096.USD","IE00B2B36J28.USD","LU2468319806.SGD","LU2129689431.USD","IE00BJJMRZ35.SGD","LU2430703251.USD","BK4592","IE00BVYPNW00.USD","IE00BN8TJ469.HKD","IE00BFXG1179.USD","LU2471134796.USD","LU0795875169.SGD","LU1196500208.SGD","LU1061106388.HKD","IE00B4R5TH58.HKD","IE00BVYPNV92.GBP","IE0034235303.USD","LU0345769631.USD","IE00BLSP4452.SGD","LU0122379950.USD","LU1074936037.SGD","LU1221951046.USD","IE00B19Z3B42.SGD","LU2430703178.SGD","IE000M9KFDE8.USD","LU1032466523.USD","LU1929549753.HKD","LU2471134952.CNY","LU1894683264.USD","LU2592432038.USD","BK4532","BK4588","LU0070217475.USD","LU2129689605.HKD","IE0002141913.USD","LU0058720904.USD","LU0466842654.USD","LU0432979614.USD","IE0009355771.USD","LU1674673428.USD","IE00BLSP4239.USD","LU0889566641.SGD","BK4559","LU1718418525.SGD","LU1066053197.SGD","LU2505996681.GBP","LU0234572021.USD","LU0985320562.USD","SG9999002232.USD","IE00BFTCPJ56.SGD","LU2471134879.HKD","LU2112291526.USD","SG9999002224.SGD","LU0792757196.USD","IE00BDGV0183.EUR","LU1280957306.USD","LU0203347892.USD","LU1244550577.SGD","LU1267930813.SGD","LU1221951129.SGD","LU0203345920.USD","LU2505996509.AUD","LU2430703095.HKD","BK4550","BK4581","IE00BJT1NW94.SGD","LU1778281490.HKD","LU1023059063.AUD","IE00B3T34201.USD","LU1244550221.USD","LU0320765646.SGD","LU1935042991.SGD","BK4585","LU1261432733.SGD","BK4007","LU1506573853.SGD","IE00BBT3K403.USD","LU1162221912.USD","IE00B19Z3581.USD"],"gpt_icon":0},{"id":"1145436213","title":"Nanobiotix Sa - 關於Nanoray-312及其他與Jnj-1900 (Nbtxr3)相關的強生讚助研究的未來指引將由強生髮布","url":"https://stock-news.laohu8.com/highlight/detail?id=1145436213","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1145436213?lang=zh_tw&edition=fundamental","pubTime":"2025-10-24 14:02","pubTimestamp":1761285761,"startTime":"0","endTime":"0","summary":"Nanobiotix Sa - 关于Nanoray-312及其他与Jnj-1900 (Nbtxr3)相关的强生赞助研究的未来指引将由强生发布","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1074936037.SGD","IE00BVYPNW00.USD","LU1674673428.USD","IE00B2B36J28.USD","LU0912757837.SGD","LU1506573853.SGD","LU2129689431.USD","LU0640476718.USD","LU1718418525.SGD","LU0289739699.SGD","LU1196500208.SGD","LU0234570918.USD","LU0795875169.SGD","BK4550","IE00B19Z3B42.SGD","LU1162221912.USD","LU1261432733.SGD","LU0345770308.USD","BK4585","IE00B7SZLL34.SGD","LU1066051498.USD","IE00BSNM7G36.USD","IE00B4R5TH58.HKD","LU1061106388.HKD","LU0432979614.USD","LU0122379950.USD","IE00BVYPNV92.GBP","LU0466842654.USD","SG9999001440.SGD","LU0203345920.USD","LU1894683264.USD","IE00B19Z3581.USD","LU0070217475.USD","LU2133065610.SGD","LU0234572021.USD","LU1023059063.AUD","LU1244550494.USD","IE00B3PB1722.GBP","LU0203347892.USD","BK4532","LU2430703178.SGD","IE00BN8TJ469.HKD","LU2592432038.USD","IE00BJT1NW94.SGD","IE0002270589.USD","SG9999002232.USD","LU2505996509.AUD","IE00BLSP4452.SGD","BK4533","LU2129689605.HKD","LU2471134796.USD","LU1585245621.USD","IE00BDGV0183.EUR","LU1267930813.SGD","LU0345770993.USD","LU1244550577.SGD","LU0889566641.SGD","IE00BBT3K403.USD","LU1914381329.SGD","LU1280957306.USD","LU1732800096.USD","LU1244550221.USD","LU2430703095.HKD","LU2471134952.CNY","LU1894683348.USD","LU2505996681.GBP","IE00BFXG1179.USD","IE00B1BXHZ80.USD","LU1059921491.USD","BK4534","BK4592","LU2468319806.SGD","LU2602419157.SGD","BK4007","LU0345769631.USD","LU0985320562.USD","LU1732799900.SGD","IE00BJJMRZ35.SGD","LU1066053197.SGD","IE0002141913.USD","IE00B3T34201.USD","IE000M9KFDE8.USD","BK4559","LU1032466523.USD","LU1778281490.HKD","IE00BFTCPJ56.SGD","LU1066051225.USD","IE0009355771.USD","IE00BGHQF631.EUR","LU0098860793.USD","IE00B42XCP33.USD","LU1430594728.SGD","LU0792757196.USD","LU2471134523.USD","LU0320765646.SGD","LU0114720955.EUR","LU0882574055.USD","LU1221951046.USD","LU0795875086.SGD","JNJ","LU2750360997.AUD","LU0058720904.USD","LU2347655156.SGD","LU1057294990.SGD","LU1221951129.SGD","LU1066051811.HKD","IE0034235303.USD","LU2112291526.USD","SG9999002224.SGD","LU2471134879.HKD","LU1935042991.SGD","LU2750360641.GBP","BK4568","LU1496350502.SGD","BK4504","LU2129689514.USD","LU1032955483.USD","LU1674673691.USD","BK4581","LU0345769128.USD","LU2430703251.USD","LU1929549753.HKD","LU2089984988.USD","BK4588","IE00BLSP4239.USD"],"gpt_icon":0},{"id":"2577515244","title":"Aethlon Medical, Inc.盤中異動 股價大漲5.57%","url":"https://stock-news.laohu8.com/highlight/detail?id=2577515244","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2577515244?lang=zh_tw&edition=fundamental","pubTime":"2025-10-23 22:22","pubTimestamp":1761229321,"startTime":"0","endTime":"0","summary":"北京时间2025年10月23日22时22分，Aethlon Medical, Inc.股票出现异动，股价大幅上涨5.57%。截至发稿，该股报5.12美元/股，成交量1.9431万股，换手率2.55%，振幅3.30%。Aethlon Medical, Inc.股票所在的医疗器械行业中，整体跌幅为0.87%。其相关个股中，Spectral Ai Inc C/Wts 、Owlet, Inc.、Vivos Therapeutics, Inc.涨幅较大，Intelligent Bio Solutions Inc.、Invo Fertility, Inc.、沃氪医疗较为活跃，换手率分别为41.34%、22.90%、12.56%，振幅较大的相关个股有Inspira Tech Oxy Bhn Ltd C/Wts 16/07/2026 、Envoy Medical Inc C/Wts 29/09/2028 、Integer Holdings Corporation，振幅分别为18.13%、17.82%、15.81%。Aethlon Medical, Inc.公司简介：Aethlon Medical Inc 是一家医疗技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025102322220194d9e584&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025102322220194d9e584&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AEMD","BK4583","BK4082","BK4568"],"gpt_icon":0},{"id":"1105234920","title":"Moderna股價下跌1.7%，因公司在試驗受挫後暫停鉅細胞病毒疫苗的研發","url":"https://stock-news.laohu8.com/highlight/detail?id=1105234920","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1105234920?lang=zh_tw&edition=fundamental","pubTime":"2025-10-23 21:37","pubTimestamp":1761226632,"startTime":"0","endTime":"0","summary":"Moderna股价下跌1.7%，因公司在试验受挫后暂停巨细胞病毒疫苗的研发","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4568","BK4588","BK4585","BK4548","BK4532","BK4551","BK4501","MRNA","BK4139","BK4533","BK4534"],"gpt_icon":0},{"id":"2577577300","title":"研究公司稱，如果藥物定價與基準掛鈎，美國本可節省 15 億美元成本","url":"https://stock-news.laohu8.com/highlight/detail?id=2577577300","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2577577300?lang=zh_tw&edition=fundamental","pubTime":"2025-10-23 21:36","pubTimestamp":1761226590,"startTime":"0","endTime":"0","summary":"路透10月23日 - 一个有影响力的药品定价监督机构周四的一项分析表明，如果一种药品在扣除回扣和折扣后的价格与其基准一致，那么美国在该药品获得批准后的第一年就可以节省多达15亿美元。目前，美国患者支付的处方药费用是迄今为止最高的，往往是其他发达国家的近三倍，即使政府在努力控制成本。审查结果显示，按照 ICER 的健康效益价格基准调整价格，仅在批准后的第一年就能节省约 13 亿至 15 亿美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251023:nL4S3W41AH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0985481810.HKD","BK4592","BK4599","LU1894683348.USD","LU0321505868.SGD","LU0321505439.SGD","IE0002270589.USD","SG9999002232.USD","IE00BLSP4239.USD","SG9999011175.SGD","SG9999001176.SGD","LU0225284248.USD","BK4581","IE000M9KFDE8.USD","LU0306806265.USD","LU1066051498.USD","SG9999013999.USD","BK4588","BK4585","BK4550","LU0234572021.USD","IE00B19Z3B42.SGD","SG9999001176.USD","LU0122379950.USD","LU1057294990.SGD","LU0306807586.USD","BK4533","IE00BLSP4452.SGD","IE00B19Z3581.USD","LU1023059063.AUD","BK4007","LU0170899867.USD","LU0456855351.SGD","LU0868494617.USD","LU1894683264.USD","LU0058720904.USD","SG9999002224.SGD","PFE","LU1066053197.SGD","BK4568","LU0289739699.SGD","SG9999003800.SGD","BK4534","LU0225771236.USD","SGXZ57979304.SGD","IE00BBT3K403.USD","LU1883839398.USD"],"gpt_icon":1},{"id":"2577307068","title":"跨國藥企高層：進博會強大「溢出效應」成全球創新成果落地「加速器」","url":"https://stock-news.laohu8.com/highlight/detail?id=2577307068","media":"中国新闻网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2577307068?lang=zh_tw&edition=fundamental","pubTime":"2025-10-23 21:06","pubTimestamp":1761224803,"startTime":"0","endTime":"0","summary":"中新网上海10月23日电(记者陈静)“进博会已成为全球新品首发、技术首秀和共享中国机遇的重要平台。过去连续三年参展，我们深切感受到进博会的‘溢出效应’，多款创新疗法通过‘进博快车’加速落地，更快惠及中国患者。”吉利德科学全球副总裁、中国区总经理金方千23日对记者表示。第八届中国国际进口博览会(简称：进博会)将要开幕，全球领先的生物制药企业吉利德科学将第四次亮相进博会。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202510233542559744.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202510233542559744.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["SG9999015952.SGD","IE0002270589.USD","BK4588","SG9999015986.USD","LU1066053197.SGD","LU2087621335.USD","BK4566","IE00B19Z3B42.SGD","BK4139","LU1674673428.USD","BK4532","LU0109394709.USD","LU2089984988.USD","LU1674673691.USD","LU0882574055.USD","LU1839511570.USD","LU0058720904.USD","BK4578","LU1585245621.USD","LU0889565916.HKD","LU2468319806.SGD","PBC","IE00BKVL7J92.USD","LU0234570918.USD","IE00B7SZLL34.SGD","LU0114720955.EUR","BK4550","LU1571399168.USD","LU1778281490.HKD","IE00B3T34201.USD","BK4583","IE00BSNM7G36.USD","SG9999015978.USD","LU1430594728.SGD","IE00B19Z3581.USD","SG9999015945.SGD","BK4585","LU2324357040.USD","IE00BZ1G4Q59.USD","BK4568","LU0823416689.USD","LU1066051498.USD","LU0320765992.SGD","GILD","LU0289739699.SGD"],"gpt_icon":0},{"id":"1163590253","title":"吉利德展示Livdelzi®（Seladelpar）在原發性膽汁性膽管炎（PBC）中的長期療效階段性數據以及針對慢性乙型肝炎的研究藥物Bulevirtide","url":"https://stock-news.laohu8.com/highlight/detail?id=1163590253","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1163590253?lang=zh_tw&edition=fundamental","pubTime":"2025-10-23 20:00","pubTimestamp":1761220836,"startTime":"0","endTime":"0","summary":"吉利德展示Livdelzi®（Seladelpar）在原发性胆汁性胆管炎（PBC）中的长期疗效阶段性数据以及针对慢性乙型肝炎的研究药物Bulevirtide","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2468319806.SGD","IE00B19Z3581.USD","LU0889565916.HKD","LU0882574055.USD","LU0114720955.EUR","LU0058720904.USD","BK4585","LU1674673691.USD","BK4588","LU1778281490.HKD","LU0289739699.SGD","IE00BZ1G4Q59.USD","SG9999015945.SGD","LU1066053197.SGD","IE00B7SZLL34.SGD","LU0109394709.USD","BK4139","IE00BSNM7G36.USD","LU1674673428.USD","LU0234570918.USD","SG9999015952.SGD","BK4566","BK4578","LU1571399168.USD","LU2087621335.USD","BK4583","SG9999015978.USD","LU1430594728.SGD","LU1839511570.USD","IE00BKVL7J92.USD","BK4550","LU2089984988.USD","IE0002270589.USD","LU1585245621.USD","BK4532","IE00B19Z3B42.SGD","LU0823416689.USD","LU1066051498.USD","LU2324357040.USD","SG9999015986.USD","LU0320765992.SGD","GILD","BK4568","IE00B3T34201.USD"],"gpt_icon":0},{"id":"2577374932","title":"BUZZ-出生缺陷疫苗試驗未達標，莫德納股價下跌","url":"https://stock-news.laohu8.com/highlight/detail?id=2577374932","media":"路透中文","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2577374932?lang=zh_tw&edition=fundamental","pubTime":"2025-10-23 17:28","pubTimestamp":1761211691,"startTime":"0","endTime":"0","summary":"10月23日 - ** 生物技术公司莫德纳 MRNA.O在试验受挫后停止开发出生缺陷疫苗 ，盘前股价下跌3.5%，至25.91美元。** 实验性巨细胞病毒 mRNA-1647疫苗在7500名妇女中的有效率为6%至23%，未达到公司在最后阶段试验中设定的目标。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251023:nL4T3W40P1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4532","BK4533","BK4551","MRNA","BK4548","BK4534","BK4585","BK4588","BK4568","BK4501"],"gpt_icon":0},{"id":"1142817684","title":"Moderna股價在盤前交易中下跌4.3%，因公司因試驗挫折暫停出生缺陷疫苗的開發","url":"https://stock-news.laohu8.com/highlight/detail?id=1142817684","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1142817684?lang=zh_tw&edition=fundamental","pubTime":"2025-10-23 16:14","pubTimestamp":1761207253,"startTime":"0","endTime":"0","summary":"Moderna股价在盘前交易中下跌4.3%，因公司因试验挫折暂停出生缺陷疫苗的开发。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4534","BK4501","MRNA","BK4533","BK4585","BK4568","BK4551","BK4532","BK4588","BK4548"],"gpt_icon":0},{"id":"2577066319","title":"試驗失敗後，莫德納 終止了 CMV 疫苗的研發","url":"https://stock-news.laohu8.com/highlight/detail?id=2577066319","media":"路透中文","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2577066319?lang=zh_tw&edition=fundamental","pubTime":"2025-10-23 04:32","pubTimestamp":1761165159,"startTime":"0","endTime":"0","summary":"试验失败后，莫德纳 终止了 CMV 疫苗的研发路透10月22日 - 莫德纳 MRNA.O周三表示，由于未能达到后期试验的主要目标，该公司将停止开发预防巨细胞病毒（一种导致出生缺陷的常见病毒）的试验性疫苗。(为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。)","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251022:nL4T3W31IX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4533","BK4548","BK4551","BK4568","BK4532","BK4139","BK4534","BK4501","BK4588","BK4585","MRNA"],"gpt_icon":0},{"id":"1114089003","title":"Moderna公佈的III期研究顯示，實驗性鉅細胞病毒(CMV)疫苗未達到主要療效指標","url":"https://stock-news.laohu8.com/highlight/detail?id=1114089003","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1114089003?lang=zh_tw&edition=fundamental","pubTime":"2025-10-23 04:29","pubTimestamp":1761164952,"startTime":"0","endTime":"0","summary":"Moderna公布的III期研究显示，实验性巨细胞病毒(CMV)疫苗未达到主要疗效指标","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4551","BK4501","BK4534","BK4548","BK4139","BK4532","BK4588","BK4533","MRNA","BK4585","BK4568"],"gpt_icon":0},{"id":"1171207561","title":"Moderna - 不預計其2025年財務指引或2028年實現盈虧平衡的預期受到任何影響","url":"https://stock-news.laohu8.com/highlight/detail?id=1171207561","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1171207561?lang=zh_tw&edition=fundamental","pubTime":"2025-10-23 04:29","pubTimestamp":1761164952,"startTime":"0","endTime":"0","summary":"Moderna - 不预计其2025年财务指引或2028年实现盈亏平衡的预期受到任何影响","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4548","BK4585","BK4588","BK4534","BK4501","BK4551","BK4568","BK4533","BK4139","BK4532","MRNA"],"gpt_icon":0},{"id":"1185297022","title":"Moderna將繼續在進行中的第二階段臨牀試驗中評估MRNA-1647在骨髓移植患者中的應用","url":"https://stock-news.laohu8.com/highlight/detail?id=1185297022","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1185297022?lang=zh_tw&edition=fundamental","pubTime":"2025-10-23 04:29","pubTimestamp":1761164952,"startTime":"0","endTime":"0","summary":"Moderna将继续在进行中的第二阶段临床试验中评估MRNA-1647在骨髓移植患者中的应用","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MRNA","BK4568","BK4501","BK4588","BK4585","BK4551","BK4548","BK4139","BK4533","BK4534","BK4532"],"gpt_icon":0},{"id":"1178018455","title":"Vir Biotechnology將在2025年11月5日發佈企業更新及2025年第三季度財務業績","url":"https://stock-news.laohu8.com/highlight/detail?id=1178018455","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1178018455?lang=zh_tw&edition=fundamental","pubTime":"2025-10-23 04:06","pubTimestamp":1761163572,"startTime":"0","endTime":"0","summary":"Vir Biotechnology将在2025年11月5日发布企业更新及2025年第三季度财务业绩。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","BK4139","BK4535","VIR","BK4568"],"gpt_icon":0},{"id":"2577136616","title":"波士頓科學公司因心臟設備需求強勁而上調年度利潤預期","url":"https://stock-news.laohu8.com/highlight/detail?id=2577136616","media":"路透中文","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2577136616?lang=zh_tw&edition=fundamental","pubTime":"2025-10-22 19:33","pubTimestamp":1761132825,"startTime":"0","endTime":"0","summary":"路透10月22日 - 波士顿科学公司周三上调了年度利润预期，此前这家医疗设备制造商因心脏设备需求强劲而超过了第三季度利润预期。波士顿科学公司还生产胃肠道和肺部治疗设备，该公司预计2025年调整后每股利润将在3.02美元至3.04美元之间，而之前的区间为2.95美元至2.99美元。公司心血管部门的季度销售额为 33.4 亿美元，高于预期的 32.7 亿美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251022:nL4S3W30SG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BJJMRZ35.SGD","ABT","BSX","LU0640476718.USD","LU1674673428.USD","LU2471134879.HKD","IE00B19Z3581.USD","IE000M9KFDE8.USD","LU0795875169.SGD","LU1061106388.HKD","BK4568","LU0070217475.USD","IE00B42XCP33.USD","LU0320765646.SGD","LU1267930813.SGD","LU1221951129.SGD","LU1221951046.USD","SGXZ57979304.SGD","SG9999002232.USD","LU2471134523.USD","SG9999004303.SGD","LU1720051017.SGD","IE00BN8TJ469.HKD","IE00BGHQF631.EUR","LU2602419157.SGD","LU0203347892.USD","LU0889566641.SGD","IE00B19Z3B42.SGD","SG9999002224.SGD","JNJ","LU0289739699.SGD","LU2471134952.CNY","LU2244417387.USD","LU2471134796.USD","LU1074936037.SGD","IE00B3PB1722.GBP","LU1244550221.USD","LU1496350502.SGD","LU0345770308.USD","LU0950375773.USD","LU0077335932.USD","LU1261432733.SGD","IE00BVYPNW00.USD","LU0122379950.USD","BK4585","SG9999001176.SGD","LU1032466523.USD","LU1674673691.USD","BK4588","IE00B4R5TH58.HKD"],"gpt_icon":0},{"id":"2577025366","title":"中文去中心化合約交易所孫悟空上線 APT、NEAR、TAO、SNX、KGEN USDT 本位合約交易","url":"https://stock-news.laohu8.com/highlight/detail?id=2577025366","media":"链捕手","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2577025366?lang=zh_tw&edition=fundamental","pubTime":"2025-10-22 19:13","pubTimestamp":1761131590,"startTime":"0","endTime":"0","summary":" ChainCatcher 消息，全球首个中文去中心化合约交易所孙悟空日前已新增 APT、NEAR、TAO、SNX、KGEN USDT 本位合约交易，支持最高 20 倍杠杆。\n据官方社媒消息，孙悟空昨日新增用户超 1500 人，目前平台累计交易额突破 24 亿 USDT，总资沉达 7100 万 USDT。此外，第 3 期迎新盛典活动目前正在进行中，总奖池 180 万枚 SUN 代币，新用户完成充值、交易、邀请好友、建议反馈等任务，即可瓜分奖励。 ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.chaincatcher.com/article/2214379","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NEAR","APT","SNX.USD.HKCC","TAO","BK4086","SNX.USD.CC","BK4568","BK4140","USDT.USD.CC","SNX","APT.USD.HKCC","APT.USD.CC"],"gpt_icon":0}],"pageSize":20,"totalPage":6,"pageCount":1,"totalSize":102,"code":"91000000","status":"200"}]}}